The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1305
February 9, 2009
View Complete Issue         Table of Contents 2019 
Repetitive Transcranial Magnetic Stimulation (TMS) for Medication-Resistant Depression
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Repetitive Transcranial Magnetic Stimulation (TMS) for Medication-Resistant Depression
February 9, 2009 (Issue: 1305)
The FDA has cleared a new device for treatment of major depressive disorder (MDD) resistant to antidepressant medication. The NeuroStar TMS System (Neuronetics) produces pulsed magnetic fields that can induce electrical currents in the brain. Unlike...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Repetitive Transcranial Magnetic Stimulation (TMS) for Medication-Resistant Depression
Article code: 1305c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.